Serum Institute Of India

Billionaire vaccine maker Adar Poonawalla bought the stake for Rs 1,000 crore. Social media users called the development 'a booster shot for Bollywood'.

SII to acquire 20% stake in IntegriMedical

IntegriMedical has developed a US patented needle-free Injection System (N-FIS) that utilises high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs, Serum Institute of India (SII) said in a statement.

Stopped manufacturing, supply of Covishield vaccine since December 2021: Serum Institute

The Indian drugmaker said it is committed to transparency and safety and had taken all the required steps to disclose the rare side effects of the vaccine

India's Serum looks beyond COVID with new vaccines for malaria, dengue

The company currently sells about 1.5 billion total vaccine doses every year, and estimates a total production capacity of as much as 4 billion doses.

Biocon-Serum deal: Serum to double investment in Biocon's unit to $300 million

Serum Life Sciences would make an additional equity investment of $150 million through the conversion of the $150 million loan provided to Biocon Pharma Limited.

Oxford University, Serum Institute of India tie-up delivers ‘high efficacy’ malaria vaccine

The R21/Matrix-M vaccine, leveraging Novavax's adjuvant technology, has been approved for use by Africa's Food and Drugs Authority in Ghana for children aged 5 to 36 months - the age group at the highest risk of death from malaria.

Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield

He said the company already has six million booster doses of Covovax vaccine available and adults must take the booster shot.

Adar Poonawalla advises elderly to mask up, take Covovax booster as COVID cases rise

Proposing the uptake of newly approved COVID vaccine, the CEO of Serum Institute said Omicron XBB & its variants can be severe for the elderly.

Wockhardt looks to roll out 2 vaccines from UK plant in 12 months as part of tie-up with Serum

Last year, a Wockhardt unit tied up with a subsidiary of Serum Institute of India to set up a vaccine manufacturing facility in Wrexham, North Wales (UK).

Serum Institute to establish CoE for Infectious Diseases and Pandemic Preparedness in T'gana

The centre “Dr Cyrus Poonawalla Center of Excellence for Infectious Diseases and Pandemic Preparedness” will be located at the Indian Institute of Public Health, a release said.

COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla

He said everyone was looking at India, not just in terms of healthcare but because the country managed to take care of a huge and diverse population and also helped 70 to 80 nations during the COVID-19 pandemic.

Serum Institute seeks drug regulator's approval for market authorisation of its Covid vaccine as booster dose

Covovax is manufactured through technology transfer from Novavax. It has been approved by the European Medicines Agency for conditional marketing authorisation.

News of rising Covid cases in China is concerning, says Adar Poonawalla

Serum Institute of India chief Adar Poonawalla says that news of surging Covid cases in China is concerning, but India, with its excellent vaccination coverage, does not need to panic.

Graduates pose as Adar Poonawalla, cheat Serum Institute of Rs 1 crore: Police

To commit fraud, the accused persons made a WhatsApp account with Adar Poonawalla's photo.

Nigeria to produce vaccines locally with Serum Institute of India

The venture between Bio Vaccine Nigeria and Serum Institute would start by producing 15% of vaccines used in local immunisation.

Fraudsters dupe Serum Institute of Rs 1 crore by asking for money transfer in CEO's name

The fraud unfolded between the afternoons of Wednesday and Thursday, said an official of Bundgarden police station.

Bill Gates, Serum Institute get Bombay HC notice after man claims Covishield side-effects killed daughter

Petitioner Dilip Lunwat, the petitioner, said his daughter, a medical student, had severe headaches and vomiting after taking the vaccine in 2021. She was taken to a hospital where doctors found bleeding in her brain.

HC seeks response from SII, others on plea demanding Rs 1,000 crore compensation for woman's death

Petitioner Dilip Lunwat has also made Microsoft founder Bill Gates whose foundation had partnered with the SII, the Union government, Maharashtra government and Drug Controller of India respondents to the plea.

SII will try to launch Omicron-specific vaccine after six months: Adar Poonawalla

Speaking to reporters on the sidelines of an event, he said there is good data available for Covavax vaccine.

US envoy, Novovax CEO hail role played by India and SII during COVID-19 pandemic

A US delegation comprising Lacina, US Consul General in Mumbai Mike Hankey, CEO of Novovax Inc Stanley C Erck, and others visited Serum Institute of India (SII) headquarters in Pune and met its CEO Adar Poonawalla to celebrate 75 years of the US-India bilateral partnership.

MC Exclusive | Awaiting govt direction for developing monkeypox vaccine: Adar Poonawalla

The CEO of Serum Institute says the company is in talks with three drug makers. He says the company has built an additional capacity and now has a vaccine-making capacity of 4 billion doses.

Serum Institute in talks with Danish firm to import monkeypox vaccine

In case of a collaboration it could take two to three months to import the vaccine into the country, Poonawalla said in an interview to news channel NDTV.

MC Explains | What is Cervavac? India’s first cervical cancer vaccine

India shares more than a quarter of the global cervical cancer burden although the country contributes 17 percent of the world’s population.

Centre plans second-generation COVID vaccines to tackle mutating variants 

But immunologists are not convinced, noting that new vaccines may not be needed as COVID has become endemic. 

NTAGI to review trial data on Serum Institute of India's qHPV vaccine against cervical cancer

A separate HPV working group of the National Technical Advisory Group on Immunisation (NTAGI) had examined on June 8 the clinical trial data and usefulness of the vaccine for inclusion in the national immunisation programme, they said.